Ob_iective: Determine the prevalence of non-albicans species in acute vulvovaginal candidiasis. Study Design: A prospective studyof 82 women with acute vulvovaginal candidiasis and 76 matched controls was performed. Women presenting with appropriate symptoms (abnormal vaginal discharge, pmritis, or burning) and either vulvar erythema or abnormal vaginal discharge identified on physical exam were evaluated via vaginal pH determination and smears for saline and potassium hydroxide microscopy. A diagnosis of acute vulvovaginal candidiasis was made in those women with a pH <4.4, the presence of buds, mycelia or pseudohyphae on microscopy. Cultures were collected from the lateral side walls and posterior fomix on Saborauds dextrose slants and identified by standard methods. Seventy-six consecutive controls from a contraception clinic had cultures performed as described. The patient and control populations were equally matched for age, parity and method of contraception.
Reports in which only blastospores or budding elements were identified were not included in the criteria. Out of the 207 cases in which pseudomycelia were present, 159 had quamitation of the number of white blood cells per high power field concomitantly present. One hundred and two (64%) of patients had no significant inflammation (63 had less than 2 WBC/hpf, 39 had less than 3-5 WBC/hpf). Thirty-five patients (22%) had minimal to moderate inflammation (5-10 WBC/hpf). A commonly recited tenet of medicine is that antibiotic use is often complicated by vulvovaginal candidiasis (vvc) . We wondered how strong this association is and whether it is applicable to current prescribing practices. We undertook a prospective, longitudinal culture-based observational study of 250 women followed from their first prenatal visit through their six weeks postpartum visit, documenting antibiotic use, complaints, signs and symptoms of yeast vaginits. Vaginal culture for Candida was done at the first visit and in each patient who developed symptoms. Patients symptomatic at their first visit were excluded from this evaluation. Study participants were categorized as colonized or uncolonized based on their first visit culture. We found a significantly increased risk of developing symptoms among women who were asymptomatically colonized. For the entire period of observation there was a 10.9% risk of any patient becoming symptomatic, but a 5.1% risk of becoming symptomatic after antibiotic treatment. Among the patients in our study, 43%
were treated with at least one course of antibiotic and several patients were treated with multiple courses of antibiotics without developing vaginitis symptoms. Antibiotics were prescribed by family practicioners, emergency room physicians, dentists, dermatologists or surgeons, illustrating the need for obstetrician to be aware that their obstetrical patients may use various drugs without the advice of the obstetrician. All cases of symptomatic infection occurred prior to delivery and no cases were seen between delivery and the 6 week postpartum visit, indication that pregnancy and vaginal colonization are more significant risk factors for symptomatic vvc, than is antibiotic treatment. Objective: There is a significant increase in the incidence of pyelonephritis in pregnant population. The pathogenesis of pyelonephritis in non-pregnant population has been associated with bacterial virulence factors, such as 'P' fimbriae, present in about 70-90% of all pyelonephritis cases. We hypothesize that during pregnancy there .is an increase in the expression of host receptors for 'P' fimbriae of uropathogenic E. coli and this increase may result.in an increased colonization leading to an increased incidence of pyelonephritis during pregnancy. Study Design: Kidney sections obtained from C3H/HeJ mice at difference gestational ages were fixed in acetone and incubated with FITC labelled E. coli strains expressing pap-1 and pap-2 fimbriae for one-hour and after washing with PBS, sections were viewed under fluorescent microscope.
Results: Significant increase in the attachment of pap-1 fimbriated E. coli was observed during the first half of pregnancy whereas there was increased attachment of pap-2 during the second half of the pregnancy. Conclusions: The dynamic change in the attachment of pap l and pap2 fimbriated E.coli to C3H/HeJ mice kidney appears to be in agreement with our hypothesis that there may be an increase in the expression of specific tissue receptors during pregnancy that promote colonization by E. coli bearing these specific virulence factors. We, therefore, propose that over-expression of tissue receptors may be an important factor in the pathogenesis of pyelonephritis in pregnant population. Most women with occluded fallopian tubes never had symptoms of a chlamydial infection but have antibodies to C. trachomatis. Detection of asymptomatic carrier of C. trachomatis is essential to reduce the incidence of negative sequela of a chlamydial infection as well as decrease its rate of transmission. Screening women for C. trachomatis involves a speculum examination and endocervical sampling. This may be unacceptable or unavailable to some women at risk for infection. We evaluated whether self-collection of introital samples was an alternative to obtain specimens for C. trachomatis detection. An illustrated brochure was developed which prescribed the procedure for self-collection of introital samples. Patients consisted of 62 women attending an outpatient clinic, some of whom had tested positive for C. trachomatis by DNA probe on their previous visit and were retuming for treatment. After the self-sample was collected, the clinician collected a second introital sample followed by an endocervical sample. All samples were tested for C. trachomatis by Amplicor polymerase chain reaction (PCR). The self-collected introital sample was positive for C. trachomatis in 17 (27.4%) women. These same women but none of the others were also positive in the clinician-collected introital sample. All but one of these women, and none of the others, were also positive for C. trachomatis in the endocervix. With proper instruction self-collected introital sampling is a viable altemative to endocervical sampling for C. trachomatis infections in women. The availability of this option should greatly increase the numbers of women for whom C. trachomatis testing can now be performed. It has been accepted since the late 19th Century that lactobacilli are the normal flora in almost all women. The metabolic activities of the lactobacilli, which include the maintenance of an acidic pH, the production of antimicrobial substances, enhancement of host resistance, as well as other favorable actions, have been studied for several years. It is well known that if the appropriate lactobacilli are scant or absent, the risk of acquiring certain infections are increased. Regrettable, women are susceptible to exogenous pathogens., especially STD's, even though they have "normal" flora. The appropriate protection can be life saving in our current era of HIV. As reported previously, the frequent use of Inner Confidence TM does not cause v.aginal lesions associated with the use of Nonoxynol-9 products. Inner Confidence TM destroys both the white blood cells and spermatozoa that may act as carriers of infectious organisms. It also prevents the post coital rise in vaginal pH and is compatible with latex condoms. Intravaginally, Inner Confidence TM kills Gardnerella vaginalis, Neisseria gonorrhoeae, the pyogenic cocci, the enterics, Candida species, Trichomonas vaginalis, Chlamydia trachomatis, Herpes simplex I and II, HIV, and other pathogenic and potentially pathogenic organisms. In addition to its polyantimicrobial activities, Inner Confidence's TM most important safety profile for women is the replenishing of the normal vaginal flora when the micro-encapsulated lactobacilli are released, producing hydrogen peroxide and microcidins.
